Arysta prepares for US IPO
Arysta LifeScience has filed a registration statement with the US Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of its common stock. The number of shares to be sold and the price range for the proposed offering have yet to be determined. Net proceeds from the offering will be used to repay existing debt and for general corporate purposes, according to the draft prospectus filed with the SEC. Arysta is owned by the Irish investment firm, Permira, which acquired the business in 2008 (Agrow No 539, p 4).